Search

Author/Creator Harlin, Olof

1. Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab. Issue 1 (December 2016)

Authors:
Ziemssen, Tjalf; Gass, Achim; Wuerfel, Jens; Bayas, Antonios; Tackenberg, Björn; Limmroth, Volker; Linker, Ralf; Mäurer, Mathias; Haas, Judith; Stangel, Martin; Meergans, Matthias; Harlin, Olof; Hartung, Hans-Peter
Journal:
BMC neurology
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study. Issue 8 (August 2017)

Authors:
Jurczak, Wojciech; Moreira, Ilídia; Kanakasetty, Govind Babu; Munhoz, Eduardo; Echeveste, Maria Asunción; Giri, Pratyush; Castro, Nelson; Pereira, Juliana; Akria, Luiza; Alexeev, Sergey; Osmanov, Eugeniy; Zhu, Peijuan; Alexandrova, Siyka; Zubel, Angela; Harlin, Olof; Amersdorffer, Jutta
Journal:
Lancet
Issue:
Volume 4:Issue 8(2017)
Page Start:
e350
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search